Endo Q1 Earnings Beat Estimates, Revenues In Line
Dublin, Ireland-based Endo International plc (ENDP - Free Report) is a specialty pharmaceutical company focused on branded and generic pharmaceuticals products as well as over-the-counter medications through its operating companies. The company has several products including Lidoderm, Opana ER, Supprelin LA and Fortesta Gel in its Branded Pharmaceuticals portfolio.
Endo has implemented a growth-by-acquisition strategy. The company has acquired privately held Par Pharmaceutical, which boosted its generics portfolio and pipeline. The company also acquired a broad portfolio of branded and generic injectable and established products focused on pain, anti-infectives, cardiovascular and other specialty therapeutics areas from a subsidiary of Aspen Holdings.
Endo has been consistently beating earnings expectations. In fact, Endo posted a positive surprise in each of the trailing four quarters, with an average positive surprise of 12.7%.
Currently, Endo has a Zacks Rank #3 (Hold), but that could definitely change following the company’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Endo surpassed first-quarter 2017 earnings. The company reported EPS of $1.23 while our consensus called for EPS of $1.12.
Revenues: Revenues were in line with expectations. Endo posted revenues of $1.03 billion in line with the consensus estimate.
Key Stats: Revenues were up on a year over year basis due to the launch of key first-to-file generic products for Seroquel and Zetia.
2017 Guidance: Endo expects revenues in the range of $3.45 billion to $3.60 billion. The company expects earnings from continuing operations in the range of $3.45 to $3.75 per share. The Zacks Consensus Estimate for earnings is $3.63 per share on revenues of $3.55 billion.
Pre-Market Trading: Shares did not show any movement in the pre-market trading.
Check back later for our full write up on this ENDP earnings report later!
Endo International PLC Price and EPS Surprise
Endo International PLC Price and EPS Surprise | Endo International PLC Quote
Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or ...
more